Coronavirus / COVID

Free CME webinar offers a diverse look at what it’s like on the frontlines of the COVID-19 pandemic.

Among 4 babies born with coronavirus in Wuhan, China, 1 had no noticeable symptoms.

Ramy Elshaboury, PharmD, BCPS, AQ ID, discusses the process of putting COVID-19 guidance in place using currently available literature and data.

This authorization could replenish the supply of 4 million N95 masks per day.

China may have been the early epicenter of COVID-19, but a new study finds Brazil’s outbreak is largely tied to travel from Italy.

This is the COVID-19 update for Monday, April 13, 2020.

Thomas Dilworth, PharmD, shares tips and resources that can help busy clinicians stay engaged and up to date during the COVID-19 pandemic.

A new analysis of COVID-19 pneumonia deaths shows ICU space was insufficient, and comorbidities were a major factor.

Although controlled trial results of remdesivir for COVID-19 won't be available for several weeks, early experience with compassionate use is detailed in a new NEJM report.

Loss of smell or taste has been reported to occur with COVID-19 in absence of other symptoms, heightening risk of exposure for unknowing contacts.

Emergency room doctors in Wuhan tracked their own recoveries from coronavirus using a phone app to aid researchers.

Matthew Davis, PharmD, provides an overview on the agent remdesivir.

Organizational leaders can support their health care workers fighting COVID-19 in small ways. Start by asking “what do you need?”

Check out the latest coronavirus updates from Friday, April 10th.

The emergency use authorization will support the decontamination of 750,000 N95 respirators per day in the United States

The majority of critically ill patients admitted to the ICU in Lombardy, Italy with COVID-19 were older men and required mechanical ventilation.

Medical sleuths identify potential of baricitinib for COVID-19 by using artificial intelligence to sift through available agents that act on receptors of interest.

Thomas Dilworth, PharmD, provides a recap of ACEIs, ARBs, and NSAIDs in patients with COVID-19.

The system can be used among adult patients with COVID-19 who have been admitted to the ICU and are currently experiencing or will experience respiratory failure.

Check out the latest coronavirus updates from Thursday, April 9th.

Jason Kindrachuk, PhD, explains the animal reservoir spillover events involved in the emergence of viruses like SARS-CoV-2.

As governments and tech companies rush to find ways to use technology to track the spread of the novel coronavirus, a new paper cautions governments against going so quickly that they ignore privacy concerns.

The trial will evaluate the safety and effectiveness of the agent in adults who are hospitalized with the novel virus

Krutika N. Mediwala, PharmD, BCPS, BCIDP, provides a recap of available information regarding Kaletra for the treatment of COVID-19.

Stay up to date on the latest COVID-19 news for April 8, 2020.